192 related articles for article (PubMed ID: 34726525)
21. Iodide handling disorders (NIS, TPO, TG, IYD).
Targovnik HM; Citterio CE; Rivolta CM
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):195-212. PubMed ID: 28648508
[TBL] [Abstract][Full Text] [Related]
22. Defective Levothyroxine Response in a Patient with Dyshormonogenic Congenital Hypothyroidism Caused by a Concurrent Pathogenic Variant in Thyroid Hormone Receptor-β.
Lauffer P; Bikker H; Garrelfs MR; Hillebrand JJG; de Sonnaville MCS; Zwaveling-Soonawala N; van Trotsenburg ASP
Thyroid; 2021 Nov; 31(11):1757-1762. PubMed ID: 34382419
[No Abstract] [Full Text] [Related]
23. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
25. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Bizhanova A; Kopp P
Endocrinology; 2009 Mar; 150(3):1084-90. PubMed ID: 19196800
[TBL] [Abstract][Full Text] [Related]
26. An extremely high dietary iodide supply forestalls severe hypothyroidism in Na
Ferrandino G; Kaspari RR; Reyna-Neyra A; Boutagy NE; Sinusas AJ; Carrasco N
Sci Rep; 2017 Jul; 7(1):5329. PubMed ID: 28706256
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect.
Kosugi S; Bhayana S; Dean HJ
J Clin Endocrinol Metab; 1999 Sep; 84(9):3248-53. PubMed ID: 10487695
[TBL] [Abstract][Full Text] [Related]
28. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
29. First case of fetal goitrous hypothyroidism due to SLC5A5/NIS mutations.
Stoupa A; Al Hage Chehade G; Kariyawasam D; Tohier C; Bole-Feysot C; Nitschke P; Thibault H; Jullie ML; Polak M; Carré A
Eur J Endocrinol; 2020 Nov; 183(5):K1-K5. PubMed ID: 32805706
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
De La Vieja A; Dohan O; Levy O; Carrasco N
Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
[TBL] [Abstract][Full Text] [Related]
31. Insights of Noncanonical Splice-site Variants on RNA Splicing in Patients With Congenital Hypothyroidism.
Albader N; Zou M; BinEssa HA; Abdi S; Al-Enezi AF; Meyer BF; Alzahrani AS; Shi Y
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1263-e1276. PubMed ID: 34632506
[TBL] [Abstract][Full Text] [Related]
32. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of iodide transport defect: do we need to measure the saliva/serum radioactive iodide ratio to diagnose iodide transport defect?
Fukata S; Hishinuma A; Nakatake N; Tajiri J
Thyroid; 2010 Dec; 20(12):1419-21. PubMed ID: 21054210
[TBL] [Abstract][Full Text] [Related]
34. Evolution and developmental expression of the sodium-iodide symporter (
Petersen AM; Small CM; Yan YL; Wilson C; Batzel P; Bremiller RA; Buck CL; von Hippel FA; Cresko WA; Postlethwait JH
Evol Appl; 2022 Jul; 15(7):1079-1098. PubMed ID: 35899258
[TBL] [Abstract][Full Text] [Related]
35. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
36. Compound heterozygous DUOX2 gene mutations (c.2335-1G>C/c.3264_3267delCAGC) associated with congenital hypothyroidism. Characterization of complex cryptic splice sites by minigene analysis.
Belforte FS; Citterio CE; Testa G; Olcese MC; Sobrero G; Miras MB; Targovnik HM; Rivolta CM
Mol Cell Endocrinol; 2016 Jan; 419():172-84. PubMed ID: 26506010
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
38. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
39. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
40. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
Spitzweg C; Joba W; Morris JC; Heufelder AE
Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
